Pharmacovigilance and the purpose of clinical trials
Should PD-L1 be used as a biomarker for immunotherapy in bladder cancer?
Safety and efficacy of ribociclib and letrozole in advanced breast cancer – the MONALEESA-2 trial
Overview of the National Cancer Research Institute (NCRI) Conference
Promising avenues for whole genome sequencing
Wim van Harten